PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases

Treatment of neurodegenerative diseases has become one of the most challenging topics of the last decades due to their prevalence and increasing societal cost. The crucial point of the non-invasive therapeutic strategy for neurological disorder treatment relies on the drugs’ passage through the bloo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cunha, Anthony, Gaubert, Alexandra, Latxague, Laurent, Dehay, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309027/
https://www.ncbi.nlm.nih.gov/pubmed/34371733
http://dx.doi.org/10.3390/pharmaceutics13071042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309027/
https://www.ncbi.nlm.nih.gov/pubmed/34371733
http://dx.doi.org/10.3390/pharmaceutics13071042

Ejemplares similares